TransMedics Group
(NASDAQ) TMDX
TransMedics Group Financials at a Glance
Market Cap
$2.55B
Revenue (TTM)
$635.89M
Net Income (TTM)
$171.92M
EPS (TTM)
$4.36
P/E Ratio
16.95
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Price
$74.06
Volume
26,511
Open
$75.48
Price
$74.06
Volume
26,511
Open
$75.48
Previous Close
$74.06
Daily Range
$72.94 - $75.62
52-Week Range
$60.11 - $156.00
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Price
$74.06
Volume
26,511
Open
$75.48
Previous Close
$74.06
Daily Range
$72.94 - $75.62
52-Week Range
$60.11 - $156.00
Estimated Earnings Date
Jul 30, 2026
TMDX News
TMDX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout TransMedics Group
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
898
CEO
Waleed H. Hassanein, MD
Website
www.transmedics.comHeadquarters
Andover, MA 01810, US
TMDX Financials
Key Financial Metrics (TTM)
Gross Margin
59.09%
Operating Margin
14.85%
Net Income Margin
27.04%
Return on Equity
41.92%
Return on Capital
11.52%
Return on Assets
11.98%
Earnings Yield
5.90%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.55B
Shares Outstanding
34.56M
Volume
26.51K
Avg. Volume
1.29M
Financials (TTM)
Gross Profit
$375.74M
Operating Income
$94.44M
EBITDA
$139.73M
Operating Cash Flow
$220.23M
Capital Expenditure
-$68.87M
Free Cash Flow
$151.36M
Cash & ST Invst.
$461.74M
Total Debt
$863.42M
TransMedics Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$173.93M
+21.2%
Gross Profit
$101.16M
+14.7%
Gross Margin
58.16%
N/A
Market Cap
$2.55B
N/A
Market Cap/Employee
$3.50M
N/A
Employees
728
N/A
Net Income
$7.32M
-71.5%
EBITDA
$27.52M
-24.1%
Quarterly Fundamentals
Total Cash
$461.74M
+48.9%
Total Debt
$863.42M
+66.6%
Accounts Receivable
$90.73M
-36.1%
Inventory
$49.89M
+15.0%
Long Term Debt
$844.91M
+63.9%
Short Term Debt
$18.51M
+563.1%
Return on Assets
11.98%
N/A
Return on Invested Capital
7.03%
N/A
Free Cash Flow
-$12.12M
+59.4%
Operating Cash Flow
$24.53M
+959.3%